Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
PRPO

PRPO - Precipio Inc Stock Price, Fair Value and News

$24.98+0.48 (+1.96%)
Market Closed

65/100

PRPO

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

65/100

PRPO

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$29.17

Target 3M

$25.63

Target 6M

$26.76

PRPO Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

PRPO Price Action

Last 7 days

1.2%

Last 30 days

7.8%

Last 90 days

22.0%

Trailing 12 Months

284.3%

PRPO RSI Chart

PRPO Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

PRPO Valuation

Market Cap

43.8M

Price/Earnings (Trailing)

-34.9

Price/Sales (Trailing)

1.92

EV/EBITDA

482.73

Price/Free Cashflow

76.78

PRPO Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$29.17

Target 3M

$25.63

Target 6M

$26.76

PRPO Fundamentals

PRPO Revenue

Revenue (TTM)

22.8M

Rev. Growth (Yr)

30.4%

Rev. Growth (Qtr)

21.77%

PRPO Earnings

Earnings (TTM)

-1.3M

Earnings Growth (Yr)

87.38%

Earnings Growth (Qtr)

-206.76%

PRPO Profitability

EBT Margin

-5.49%

Return on Equity

-9.12%

Return on Assets

-5.93%

Free Cashflow Yield

1.3%

PRPO Investor Care

Shares Dilution (1Y)

18.19%

Diluted EPS (TTM)

-0.82

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202520.0M21.2M22.8M0
202416.0M16.8M17.5M18.5M
202310.1M11.3M13.6M15.4M
20229.1M9.3M9.5M9.8M
20216.7M7.3M7.4M8.7M
20204.7M5.1M6.1M6.1M
20193.6M3.8M4.0M4.1M
20182.5M3.2M3.7M3.4M
20172.0M1.7M1.5M2.0M
20161.4M1.6M1.7M1.9M
201519.3M13.0M9.2M1.9M
201426.4M25.9M23.3M24.8M
201331.6M29.9M28.6M27.5M
201231.7M33.1M32.8M31.5M
201122.1M24.7M28.5M32.0M
201000020.0M
Get all data in R, Python etc through our Historical Stock Data APIs

About Precipio Inc

PRPO
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; and COVID-19 antibody tests. It sells ICE- technology kits to bio-pharma customers. The company is based in New Haven, Connecticut.
 CEO
 WEBSITEprecipiodx.com
 SECTORHealthcare
 INDUSTRYDiagnostics & Research
 EMPLOYEES53

Precipio Inc Frequently Asked Questions

PRPO is the stock ticker symbol of Precipio Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Precipio Inc is 43.77 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check PRPO's fair value in chart for subscribers.

The fair value guage provides a quick view whether PRPO is over valued or under valued. Whether Precipio Inc is cheap or expensive depends on the assumptions which impact Precipio Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PRPO.

As of Wed Jan 28 2026, PRPO's PE ratio (Price to Earnings) is -34.9 and Price to Sales (PS) ratio is 1.92. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PRPO PE ratio will change depending on the future growth rate expectations of investors.